Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Aktiva
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 13.87B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Aktiva
Perubahan
Tanggal
Agilent
USD 13.07B
252M
2026-03
Align Technology
USD 6.31B
80.48M
2026-03
Bio Techne
USD 2.55B
27.9M
2026-03
Bio-Rad Laboratories
USD 9.79B
786.5M
2026-03
Bruker
USD 6.13B
110.7M
2026-03
Celltrion
KRW 759.44B
20.32T
2025-12
Charles River Laboratories
USD 7.73B
594.89M
2026-03
Cspc Pharmaceutical
CNY 46.7B
695.56M
2025-12
Danaher
USD 83.54B
80M
2026-03
Dentsply International
USD 5.23B
200M
2026-03
Deva Holding AS
TRY 12.93B
1.83B
2023-09
Dianthus Therapeutics
USD 1.25B
715.96M
2026-03
Divis Laboratories Ltd
INR 200.33B
18.82B
2026-03
Edwards Lifesciences
USD 13.32B
376M
2026-03
Illumina
USD 6.56B
85M
2026-03
Intuitive Surgical
USD 20.11B
347.7M
2026-03
IQVIA Holdings
USD 29.68B
269M
2026-03
Kangmei Pharma
CNY 13.31B
375.64M
2026-03
Knight Therapeutics
CAD 1.05B
2.28M
2025-12
Laboratorios Farma
EUR 799.88M
99.95M
2023-12
Laboratory Of America
USD 19.09B
694.4M
2026-03
Malin Corporation
EUR 198.5M
70.1M
2024-12
Medical Developments International
AUD 63.57M
2.83M
2025-12
Mesa Laboratories
USD 434.85M
4.5M
2025-12
Mettler Toledo International
USD 3.67B
43.73M
2026-03
Myriad Genetics
USD 673.7M
32.9M
2026-03
Neuren Pharmaceuticals
AUD 342.86M
11.61M
2025-12
OraSure Technologies
USD 379.17M
24M
2026-03
Organigram Holdings
CAD 530.67M
31.54M
2025-12
Ovoca Bio
EUR 1.66M
9.75M
2025-06
Pacific Biosciences Of California
USD 782.36M
1.72M
2026-03
Pharma Mar
EUR 385.26M
9.82M
2026-03
Qiagen NV
USD 6.3B
257.54M
2025-12
Quest Diagnostics
USD 16.67B
448M
2026-03
Quidel
USD 5.63B
140.6M
2026-03
Repligen
USD 2.93B
18.93M
2026-03
Revvity
USD 12B
171.82M
2026-03
Sartorius
EUR 9.87B
154.9M
2026-03
Sino Biopharmaceutical
CNY 74.89B
9.49B
2025-06
Thermo Fisher Scientific
USD 113.28B
2.94B
2026-03
Tilray
USD 2.1B
15.95M
2025-09
Waters
USD 24.53B
19.45B
2026-03
Zealand Pharma A/S
15.95B
848.45M
2025-12
Zz Pientze Pharmaceu
CNY 18.38B
905.93M
2026-03
×